Inventiva IVEVF
NASDAQ IVEVF
$3.59 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Inventiva (IVEVF) Non Operating Income (2020 - 2021)

Inventiva (IVEVF) posted Non Operating Income of $1.7 million for Q1 2021, up 157250.38% on a QoQ basis from -$1101.5 in Q2 2020, and up 22299.64% year-over-year from N/an in Q1 2020.

Analysis

Inventiva (IVEVF) Non Operating Income (2020 - 2021) Analysis & Trends

Inventiva has reported Non Operating Income for 2 years, with the latest figure at $1.7 million in Q1 2021.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Johnson & Johnson 642.70 Bn 621.95 Bn 17.26 Bn -
2 AbbVie 440.80 Bn 434.23 Bn 12.70 Bn -
3 Merck 364.74 Bn 357.60 Bn 12.21 Bn -
4 Novartis Ag 266.37 Bn 258.68 Bn 11.24 Bn -
5 Pfizer 158.89 Bn 147.19 Bn 10.94 Bn -
6 Sanofi 52.43 Bn 45.05 Bn 10.79 Bn -
7 Revolution Medicines 44.38 Bn 44.38 Bn - -139.24 Mn
8 Incyte 25.28 Bn 20.74 Bn 1.57 Bn -
9 United Therapeutics 21.46 Bn 18.80 Bn 683.80 Mn 41.90 Mn
10 Inventiva 693.72 Mn 693.72 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 1.73 Mn
Jun 30, 2020 -1,101.46
Mar 31, 2020 7,727.57